Marché mondial des dispositifs de gestion du rythme cardiaque – Tendances et prévisions de l’industrie jusqu’en 2030

Analyse et taille du marché des dispositifs de gestion du rythme cardiaque   

Les patients souffrant de problèmes de rythme et de fréquence cardiaque peuvent maintenir un rythme cardiaque normal à l'aide d'appareils de gestion du rythme cardiaque. Les troubles cardiaques majeurs tels que l'insuffisance cardiaque, la fibrillation auriculaire , le flutter auriculaire , les symptômes précurseurs d'une crise cardiaque récente, l'ischémie coronarienne, le transport inadéquat de l'oxygène vers les muscles cardiaques, les effets secondaires pharmacologiques et les erreurs génétiques, entre autres, nécessitent l'utilisation de ces appareils. L'augmentation des maladies cardiaques, les progrès technologiques, la sensibilisation des patients et le nombre de besoins médicaux non satisfaits dans les pays en développement et sous-développés sont quelques-uns des facteurs qui propulsent le marché. Le marché mondial des dispositifs de gestion du rythme cardiaque devrait connaître une croissance significative au cours de la période de prévision de 2023 à 2030.

Data Bridge Market Research analyse que le marché mondial des dispositifs de gestion du rythme cardiaque, qui était de 19,05 milliards USD en 2022, devrait atteindre 28,69 milliards USD d'ici 2030 et devrait connaître un TCAC de 5,25 % au cours de la période de prévision de 2023 à 2030. Les « hôpitaux » dominent le segment des types de produits du marché mondial des dispositifs de gestion du rythme cardiaque en raison de la présence de médecins hautement qualifiés. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également des analyses approfondies d'experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché des dispositifs de gestion du rythme cardiaque

Market Definition

Cardiac management devices are medical instruments designed to monitor, regulate, and support the functioning of the heart. Pacemakers, for instance, are implanted devices that emit electrical signals to control irregular heartbeats and ensure a steady rhythm. Implantable cardioverter-defibrillators (ICDs) are another instance, capable of detecting and correcting dangerous heart rhythms by delivering controlled electric shocks. Cardiac resynchronization therapy (CRT) devices coordinate the contractions of the heart's chambers to improve pumping efficiency. These devices are crucial in treating conditions like arrhythmias and heart failure, significantly impacting the quality of life for patients with cardiovascular disorders.

Global Cardiac Rhythm Management Devices Market Dynamics

Drivers

• Rising Prevalence of Cardiovascular Diseases

The escalating global burden of cardiovascular diseases, including heart failure, coronary artery disease, and arrhythmias, is a primary driver for the global cardiac management devices market. Lifestyle factors such as sedentary living, unhealthy diets, and increased stress contribute to the rise in cardiovascular conditions. As these diseases become more prevalent, the demand for advanced cardiac devices for monitoring and treatment purposes intensifies, fostering market growth. In addition, the aging population worldwide further amplifies the need for effective cardiac management solutions.

• Increased Awareness of Cardiovascular Health

A heightened awareness of cardiovascular health, driven by healthcare campaigns, educational initiatives, and media coverage, plays a pivotal role in the growth of the global cardiac management devices market. Individuals are becoming more conscious of the importance of regular heart check-ups and early intervention. This increased awareness leads to a proactive approach to heart health, prompting both healthcare professionals and patients to adopt advanced cardiac management technologies. As a result, there is a positive impact on early diagnosis, treatment, and overall market expansion.

Opportunities

• Innovation and Research Opportunities

As the market expands, there is a significant opportunity for increased investment in research and development. Innovations in technologies, such as advanced sensing capabilities, miniaturization, and improved battery life for devices, can lead to the development of more efficient and patient friendly cardiac management solutions.

• Digitalization and Integration of Health Data

The growth of the market creates opportunities for the integration of digital health solutions. Remote monitoring, telemedicine, and data analytics can enhance the efficiency of cardiac management, providing continuous monitoring and personalized care. This shift towards digital health opens avenues for partnerships between device manufacturers and technology companies.

Restraints/Challenges

• Cost Constraints with Devices Used in market

The high cost associated with advanced cardiac management devices, including the initial implantation procedure and ongoing maintenance, poses a significant challenge. Affordability concerns may limit access to these life-saving technologies, particularly in regions with constrained healthcare budgets. Striking a balance between technological innovation and cost-effectiveness is crucial to ensure widespread adoption and equitable access to cardiac care.

• Limited Accessibility in Developing Regions

Access to advanced cardiac management devices faces challenges in developing regions with inadequate healthcare infrastructure. The lack of resources, trained medical professionals, and facilities capable of performing specialized procedures hinders accessibility. Addressing this challenge requires targeted investments in healthcare infrastructure, education, and strategic partnerships to extend the reach of cardiac management technologies to underserved populations, fostering global health equity.

This global cardiac management devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global cardiac management devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In October 2020, Abbott has launched its new implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices for abnormal heart rhythms and heart failure in the Indian market. The device offer new opportunities for patient engagement and remote monitoring through smartphone connectivity

Global Cardiac Rhythm Management Devices Market Scope

The global cardiac management devices market is segmented on the basis of product, application, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Pacemakers
• Defibrillators
• Cardiac Resynchronization Therapy (CRT)

Application

• Bradycardia
• Tachycardia
• Heart Failure
• Others

End User

• Hospital
• Home Care Settings
• Ambulatory Care Settings

Global Cardiac Rhythm Management Devices Market Regional Analysis/Insights

The global cardiac management devices market is analysed and market size insights and trends are provided by product, application, and end user as referenced above.

The countries covered in the global cardiac management devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the global cardiac management devices market owing to various factors such as well-established healthcare infrastructure, increasing elderly population, rapid adoption of technologically advanced products etc.

Asia-Pacific is expected to grow at the highest growth rate in the global cardiac management devices market during the forecast period of 2023 to 2030, due to the rising demand of advanced technology and improved healthcare infrastructure.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Le marché mondial des dispositifs de gestion cardiaque vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les équipements en capital, la base installée de différents types de produits pour le marché mondial des dispositifs de gestion cardiaque, l'impact de la technologie utilisant les courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché mondial des dispositifs de gestion cardiaque. Les données sont disponibles pour la période historique 2015-2020.

Analyse du paysage concurrentiel et des parts de marché mondiales des dispositifs de gestion du rythme cardiaque

Le paysage concurrentiel du marché mondial des dispositifs de gestion cardiaque fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché mondial des dispositifs de gestion cardiaque.

Certains des principaux acteurs opérant sur le marché mondial des dispositifs de gestion cardiaque sont :

• Physio-Control, Inc. (États-Unis)
• Schiller Americas, Inc. (Suisse)
• Medtronic (Irlande)
• Abbott (États-Unis)
• Boston Scientific Corporation (États-Unis)
• BIOTRONIK SE & Co. KG (Allemagne)
• General Electric (États-Unis)
• Asahi Kasei Corporation (Japon)
• MicroPort Scientific Corporation (Chine)
• NIHON KOHDEN CORPORATION (Japon)
• BPL Medical Technologies (Inde)
• Pacetronix (États-Unis)
• Osypka Medical (Allemagne)
• AliveCor, Inc (États-Unis)
• Stryker (États-Unis)
• Koninklijke Philips NV (Pays-Bas)
• LivaNova Plc (Royaume-Uni)

SKU-53696